COVID-19 Tied to 30% Increase in Abnormal Blood Fat Levels
Introduction
A recent study conducted by researchers from the Albert Einstein College of Medicine, USA, found that the COVID-19 pandemic was associated with a nearly 30% increase in cases of dyslipidemia—abnormal levels of fats, such as cholesterol, in the blood. The study involved two hundred thousand adults from Naples, Italy, and compared blood fat levels before and during the pandemic.
Study Design
The researchers analyzed data from participants over six years, split into two time frames: pre-pandemic years (2017–2019) and pandemic years (2020–2022). They excluded individuals who had already been diagnosed with dyslipidemia or were taking medications for the condition to ensure accurate comparison.
Key Findings
During the pandemic years, there was a 29% higher risk of developing dyslipidemia compared to the pre-pandemic period. This increased risk was most notable among people over 65 and those with chronic conditions, such as diabetes, obesity, respiratory issues, and cardiovascular disease. The study suggests that this rise is almost certainly related to the pandemic’s impact on health.
Possible Causes of Increased Dyslipidemia
While the exact mechanisms remain unclear, the researchers hypothesize that the SARS-CoV-2 virus may have disrupted the function of the inner lining of blood vessels, a key factor in regulating blood fat levels. This disruption could explain the observed increase in dyslipidemia cases.
Public Health Implications
Dyslipidemia is a major risk factor for cardiovascular disease. As a result, the study underscores the importance of regular lipid level monitoring, particularly for older adults and individuals with pre-existing conditions. Monitoring and treating abnormal lipid levels may help reduce the risk of heart disease, especially in those who have experienced COVID-19.
Additional Findings on Pandemic Health Impact
Previously, the research team also identified a rise in new cases of hypertension and type 2 diabetes during the pandemic. This study further highlights the pandemic’s lingering health effects, including an ongoing risk of increased cholesterol and blood fat levels even three years post-pandemic.
Conclusion
The researchers recommend that individuals, especially those at higher risk, consult healthcare providers for regular lipid testing and consider preventive measures. This proactive approach could potentially mitigate long-term cardiovascular risks associated with pandemic-related health changes.
Source: Inputs from various media Sources
Priya Bairagi
I’m a pharmacist with a strong background in health sciences. I hold a BSc from Delhi University and a pharmacy degree from PDM University. I write articles and daily health news while interviewing doctors to bring you the latest insights. In my free time, you’ll find me at the gym or lost in a sci-fi novel.
